Re:CBD Inhibits SARS-CoV-2 Replication and Promotes the Host...
by landemva on Monday August 09, 2021 @05:35PM
(#28122602)
The issue with natural products is lack of patent protection, so drug developers are unwilling to develop plant extracts. It could be reasonable to anticipate non-profits such as Johns Hopkins or Vanderbilt to pursue ideas like this, but it doesn't happen.
[ Parent
| on HN ]